Versameb Raises CHF 6 Million and Strengthens Team to Advance its VERSagile Technology Platform Towards Clinical Trials

BASEL, Switzerland, July 15, 2020 /PRNewswire/ -- Versameb AG, a biopharmaceutical company developing innovative ribonucleic acid (RNA) therapeutics, announced today the closing of a CHF 6 million seed financing round. Versameb further strengthens its team......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Wednesday, 15 July

Share |